Latest filing published 30 Sept 2020 for Theralase Technologies Inc., €96.
No signal scores available.
All filings by Shawn Shirazi on record concern Theralase Technologies Inc. Over a trading history stretching from 1 March 2019 to 30 September 2020, the count stands at 4 filings.
No open-market sale appears; the market trades are 3 purchases worth €500. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2020 alone, the filings show 3 purchases and no sales.
A typical purchase (the median) is worth €96.
Most recently, on 30 September 2020, the filings show an open-market purchase worth €96 in Theralase Technologies Inc. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations